MENU
+Compare
SLNO
Stock ticker: NASDAQ
AS OF
Sep 5, 04:59 PM (EDT)
Price
$69.74
Change
+$0.17 (+0.24%)
Capitalization
3.71B

SLNO Soleno Therapeutics Forecast, Technical & Fundamental Analysis

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases... Show more

SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SLNO with price predictions
Sep 04, 2025

SLNO's Indicator enters downward trend

The Aroon Indicator for SLNO entered a downward trend on August 26, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 219 similar instances where the Aroon Indicator formed such a pattern. In of the 219 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

SLNO moved below its 50-day moving average on August 13, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SLNO crossed bearishly below the 50-day moving average on August 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLNO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SLNO's RSI Oscillator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where SLNO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 03, 2025. You may want to consider a long position or call options on SLNO as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SLNO just turned positive on September 04, 2025. Looking at past instances where SLNO's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SLNO advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

SLNO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SLNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.432) is normal, around the industry mean (19.994). P/E Ratio (0.000) is within average values for comparable stocks, (51.700). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (97.087) is also within normal values, averaging (325.279).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SLNO is expected to report earnings to fall 112.33% to 1 cents per share on November 05

Soleno Therapeutics SLNO Stock Earnings Reports
Q3'25
Est.
$0.01
Q2'25
Beat
by $0.55
Q1'25
Missed
by $0.06
Q4'24
Missed
by $0.30
Q3'24
Missed
by $1.22
The last earnings report on August 06 showed earnings per share of -9 cents, beating the estimate of -63 cents. With 631.39K shares outstanding, the current market capitalization sits at 3.71B.
A.I. Advisor
published General Information

General Information

a developer of medical diagnostics and therapeutics based on its proprietary technology for precision metering of gas flow

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
203 Redwood Shores Parkway
Phone
+1 650 213-8444
Employees
42
Web
https://www.soleno.life
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TASVX18.480.23
+1.26%
PGIM Quant Solutions Small-Cap Val Z
BSPIX762.046.36
+0.84%
iShares S&P 500 Index Institutional
SEEIX13.960.10
+0.72%
SEI International Equity I (SIT)
EVDAX21.590.04
+0.19%
Camelot Event Driven A
BIVRX17.94-0.07
-0.39%
Invenomic Investor

SLNO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with NKTX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+3.93%
NKTX - SLNO
40%
Loosely correlated
+1.43%
SYRE - SLNO
39%
Loosely correlated
+1.07%
GRCE - SLNO
38%
Loosely correlated
+3.03%
RARE - SLNO
37%
Loosely correlated
-0.86%
IDYA - SLNO
37%
Loosely correlated
+0.27%
More